San Francisco Skyline

Arriello’s new office in San Francisco, USA.

As part of our continued expansion in the US, and especially to serve the needs of existing and potential clients in the Biotech sector, we have opened a new West Coast office location right in the heart of Biotech Bay, South San Francisco at 611 Gateway Blvd, Suite 120.

CEO Alan White comments:
“I’m really pleased to announce our first West Coast office opening, complementing our established East Coast office in Boston.

This is an exciting move further into the US market for us and our clients as we continue our expansion here in the US and other territories, and Arriello continues to deliver on its Faster, Better, Smarter promise.”

Missing image

Latest News

The benefits of using Veeva Vault Safety, for us, it means that we are able to use their reporting capabilities directly from the safety database. We are able to use the gateway connection with the regulatory authorities and with partners.
Arriello modernizes pharmacovigilance with Veeva Vault Safety.
Kieran and Nicola speaking about our latest US/UK/EU survey which provides initial feedback from senior PV and Reg professionals across 4 countries on the EMA’s new Clinical Trials Regulation (CTR) that will be fully applicable from January 31 2023.
BIO Europe 2022: Fireside chat about CTR/CTIS.
Peter Embley joins Arriello to lead it’s Regulatory Affairs team and comes with over 24 years of experience working across the Pharmaceutical, CRO and Consulting Industries.
Peter Embley appointed as Chief Regulatory Officer.